LIGAND PHARMACEUTICALS INCORPORATED Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares

LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) reported Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares of 90.65 thousand shares for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-08.

Discontinued › Income Statement › Earnings Per Share

us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares · last filed 2013-05-08

LIGAND PHARMACEUTICALS INCORPORATED incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2013-03-31 was 90.65K shares, a 204.99% increase year-over-year.
LIGAND PHARMACEUTICALS INCORPORATED incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2012-09-30 was 0.00 shares.
LIGAND PHARMACEUTICALS INCORPORATED incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2012-06-30 was 0.00 shares.
LIGAND PHARMACEUTICALS INCORPORATED incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2012-03-31 was 29.72K shares.

Period end	Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 3 month	Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 6 month	Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 9 month
2013-03-31	90.65K shares 10-Q · filed 2013-05-08
2012-09-30	0.00 shares 10-Q · filed 2012-11-14		0.00 shares 10-Q · filed 2012-11-14
2012-06-30	0.00 shares 10-Q/A · filed 2012-11-14	0.00 shares 10-Q/A · filed 2012-11-14
2012-03-31	29.72K shares 10-Q · filed 2013-05-08
2011-09-30	0.00 shares 10-Q · filed 2012-11-14		37.41K shares 10-Q · filed 2012-11-14
2011-06-30	0.00 shares 10-Q/A · filed 2012-11-14	14.73K shares 10-Q/A · filed 2012-11-14